First Trust Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.31M Buy
+174,294
New +$5.96M ﹤0.01% 1440
2025
Q3
Sell
-17,307
Closed -$512K 2603
2025
Q2
$512K Sell
17,307
-27,231
-61% -$777K ﹤0.01% 2260
2025
Q1
$1.33M Sell
44,538
-85,153
-66% -$2.6M ﹤0.01% 1941
2024
Q4
$3.72M Sell
129,691
-11,601
-8% -$384K ﹤0.01% 1528
2024
Q3
$5.46M Buy
141,292
+18,321
+15% +$653K 0.01% 1294
2024
Q2
$3.96M Buy
+122,971
New +$4.26M ﹤0.01% 1384
2023
Q3
Sell
-92,793
Closed -$1.99M 2383
2023
Q2
$1.99M Buy
92,793
+3,414
+4% +$77.5K ﹤0.01% 1703
2023
Q1
$2.14M Buy
89,379
+6,814
+8% +$181K ﹤0.01% 1665
2022
Q4
$1.92M Sell
82,565
-7,573
-8% -$153K ﹤0.01% 1714
2022
Q3
$1.44M Buy
90,138
+39,065
+76% +$689K ﹤0.01% 1848
2022
Q2
$905K Sell
51,073
-2,362
-4% -$39.7K ﹤0.01% 2018
2022
Q1
$1.09M Sell
53,435
-3,076
-5% -$58.1K ﹤0.01% 2020
2021
Q4
$1.06M Buy
56,511
+5,841
+12% +$114K ﹤0.01% 2030
2021
Q3
$1M Buy
+50,670
New +$1.1M ﹤0.01% 2037

Other funds holding COLL

First Trust Advisors's COLL Position: Q2 2026 in Review

First Trust Advisors opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 174,294 shares worth $6.31M. The stake represents ﹤0.01% of the portfolio and ranks #1440 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in COLL as recently as Q2 2025.

First Trust Advisors first reported a position in COLL in Q3 2021 and has held it in 14 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • First Trust Advisors held 174,294 shares of Collegium Pharmaceutical worth $6.31M as of Q2 2026.
  • Collegium Pharmaceutical was a new First Trust Advisors position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1440 holding.
  • First Trust Advisors first reported a position in Collegium Pharmaceutical in Q3 2021 and has held it in 14 quarters since.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.